Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Nierkens

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Current Protocols in Toxicology|October 10, 2012
The reporter antigen popliteal lymph node assayStefan Nierkens, Raymond Pieters
Current Opinion in Allergy and Clinical Immunology|June 30, 2005
Murine models of drug hypersensitivityStefan Nierkens, Raymond Pieters
Drug Discovery Today. Technologies|July 2, 2014
Assessment of drug-induced immunotoxicity in animal modelsFemke van Wijk, Stefan Nierkens
Cancers|November 12, 2013
Harnessing dendritic cells for tumor antigen presentationStefan Nierkens, Edith M Janssen
Immunotargets and Therapy|April 1, 2024
Thymic NK-Cells and Their Potential in Cancer ImmunotherapyCaitlyn Forbes, Stefan Nierkens, Annelisa M Cornel
Frontiers in Pediatrics|September 25, 2020
Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and StandardizationJaap Jan Boelens, Kinga K Hosszu, Stefan Nierkens
Blood|October 5, 2016
Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitutionCoco de Koning, Stefan Nierkens, Jaap Jan Boelens
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 21, 2004
Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugsStefan Nierkens, Leonie Nieuwenhuijsen, Mieke Thomas, et al.
Cancers|July 8, 2020
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer ImmunotherapyAnnelisa M Cornel, Iris L Mimpen, Stefan Nierkens
Trends in Immunology|April 2, 2013
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?Stefan Nierkens, Jurjen Tel, Edith Janssen, et al.
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Current Protocols in Toxicology|October 10, 2012
The reporter antigen popliteal lymph node assayStefan Nierkens, Raymond Pieters
Current Opinion in Allergy and Clinical Immunology|June 30, 2005
Murine models of drug hypersensitivityStefan Nierkens, Raymond Pieters
Drug Discovery Today. Technologies|July 2, 2014
Assessment of drug-induced immunotoxicity in animal modelsFemke van Wijk, Stefan Nierkens
Cancers|November 12, 2013
Harnessing dendritic cells for tumor antigen presentationStefan Nierkens, Edith M Janssen
Immunotargets and Therapy|April 1, 2024
Thymic NK-Cells and Their Potential in Cancer ImmunotherapyCaitlyn Forbes, Stefan Nierkens, Annelisa M Cornel
Frontiers in Pediatrics|September 25, 2020
Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and StandardizationJaap Jan Boelens, Kinga K Hosszu, Stefan Nierkens
Blood|October 5, 2016
Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitutionCoco de Koning, Stefan Nierkens, Jaap Jan Boelens
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 21, 2004
Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugsStefan Nierkens, Leonie Nieuwenhuijsen, Mieke Thomas, et al.
Cancers|July 8, 2020
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer ImmunotherapyAnnelisa M Cornel, Iris L Mimpen, Stefan Nierkens
Trends in Immunology|April 2, 2013
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?Stefan Nierkens, Jurjen Tel, Edith Janssen, et al.
Pageof 19